+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anticoagulant Reversal Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 91 Pages
  • May 2025
  • Region: Global
  • Prof Research
  • ID: 6090495
Description Jump to:
Anticoagulant reversal drugs, including prothrombin complex concentrates, phytonadione, and andexanet alfa, manage bleeding risks in patients on anticoagulants for conditions like atrial fibrillation (AF, 60 million globally) and venous thromboembolism (VTE, 10 million annually). The market is driven by rising anticoagulant use, with 3-5% annual bleeding rates in elderly patients, and urgent needs in emergencies like stroke (795,000 U.S. cases yearly). The aging population (1 billion over 60 in 2020, projected to reach 2.1 billion by 2050) and COVID-19-related clotting issues further boost demand. The global anticoagulant reversal drugs market is estimated at USD 800-1,500 million in 2025, with a CAGR of 9%-13% through 2030.

Regional Market Trends

  • North America: The U.S. leads with high AF prevalence and andexanet alfa adoption, while Canada focuses on emergency care.
  • Europe: Germany, France, and the UK drive growth with robust anticoagulation programs.
  • Asia Pacific: China and India see rising demand due to aging populations, with Japan emphasizing reversal agents.
  • Rest of the World: Brazil expands stroke management, while the Middle East addresses cardiovascular care.

Distribution Channel Analysis

  • Hospital Pharmacies: Expected growth of 9.5%-13.5%, driven by emergency use. Trends focus on critical care.
  • Retail Pharmacies: Projected growth of 8.5%-12.5%, linked to outpatient management. Advances emphasize accessibility.
  • Online Pharmacies: Anticipated growth of 9.0%-13.0%, for follow-up therapies. Trends highlight digital access.

Type Analysis

  • Prothrombin Complex Concentrates: Expected growth of 9.2%-13.2%, valued for rapid reversal. Trends focus on 4F-PCC formulations.
  • Phytonadione (Vitamin K): Projected growth of 8.8%-12.8%, used for warfarin reversal. Advances emphasize oral agents.
  • Andexanet Alfa: Anticipated growth of 10.0%-14.0%, for DOAC reversal. Trends highlight high-efficacy agents.
  • Idarucizumab: Expected growth of 9.5%-13.5%, specific to dabigatran. Developments prioritize targeted therapies.
  • Protamine: Expected growth of 8.5%-12.5%, for heparin reversal. Trends focus on surgical applications.
  • Others: Expected growth of 8.0%-12.0%, covering novel agents. Developments prioritize broad-spectrum reversal.

Key Market Players

  • Boehringer Ingelheim: Offers idarucizumab for dabigatran reversal.
  • AstraZeneca: Develops anticoagulant management therapies.
  • CSL Behring: Provides prothrombin complex concentrates.
  • Pfizer: Supplies reversal agents for emergencies.
  • Octapharma: Focuses on plasma-derived therapies.

Porter’s Five Forces Analysis

  • Threat of New Entrants: Low, due to high R&D costs and regulatory barriers.
  • Threat of Substitutes: Low, as reversal agents are critical for emergencies, with few alternatives.
  • Bargaining Power of Buyers: Moderate, with hospitals negotiating prices, but urgent needs limit leverage.
  • Bargaining Power of Suppliers: Low, with multiple providers of active ingredients.
  • Competitive Rivalry: Moderate, with players competing on efficacy and specificity.

Market Opportunities and Challenges

Opportunities:

  • Addressing AF, affecting 60 million people.
  • Managing VTE, impacting 10 million annually.
  • Leveraging an aging population, with 3-5% bleeding risk.
  • Supporting stroke management, with 795,000 U.S. cases yearly.
  • Addressing COVID-19 clotting complications.
  • Expanding emergency care in developing regions.

Challenges:

  • High costs of novel reversal agents like andexanet alfa.
  • Regulatory delays for new therapies.
  • Limited access in low-income regions.
  • Complexity in managing diverse anticoagulants.
  • Risk of adverse reactions requiring monitoring.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Anticoagulant Reversal Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Anticoagulant Reversal Drug Market in North America (2020-2030)
8.1 Anticoagulant Reversal Drug Market Size
8.2 Anticoagulant Reversal Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 Anticoagulant Reversal Drug Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Anticoagulant Reversal Drug Market in South America (2020-2030)
9.1 Anticoagulant Reversal Drug Market Size
9.2 Anticoagulant Reversal Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 Anticoagulant Reversal Drug Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Anticoagulant Reversal Drug Market in Asia & Pacific (2020-2030)
10.1 Anticoagulant Reversal Drug Market Size
10.2 Anticoagulant Reversal Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 Anticoagulant Reversal Drug Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Anticoagulant Reversal Drug Market in Europe (2020-2030)
11.1 Anticoagulant Reversal Drug Market Size
11.2 Anticoagulant Reversal Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 Anticoagulant Reversal Drug Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Anticoagulant Reversal Drug Market in MEA (2020-2030)
12.1 Anticoagulant Reversal Drug Market Size
12.2 Anticoagulant Reversal Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 Anticoagulant Reversal Drug Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Anticoagulant Reversal Drug Market (2020-2025)
13.1 Anticoagulant Reversal Drug Market Size
13.2 Anticoagulant Reversal Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 Anticoagulant Reversal Drug Market Size by Type
Chapter 14 Global Anticoagulant Reversal Drug Market Forecast (2025-2030)
14.1 Anticoagulant Reversal Drug Market Size Forecast
14.2 Anticoagulant Reversal Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 Anticoagulant Reversal Drug Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Boehringer Ingelheim
15.1.1 Company Profile
15.1.2 Main Business and Anticoagulant Reversal Drug Information
15.1.3 SWOT Analysis of Boehringer Ingelheim
15.1.4 Boehringer Ingelheim Anticoagulant Reversal Drug Revenue, Gross Margin and Market Share (2020-2025)
15.2 AstraZeneca
15.2.1 Company Profile
15.2.2 Main Business and Anticoagulant Reversal Drug Information
15.2.3 SWOT Analysis of AstraZeneca
15.2.4 AstraZeneca Anticoagulant Reversal Drug Revenue, Gross Margin and Market Share (2020-2025)
15.3 CSL Behring
15.3.1 Company Profile
15.3.2 Main Business and Anticoagulant Reversal Drug Information
15.3.3 SWOT Analysis of CSL Behring
15.3.4 CSL Behring Anticoagulant Reversal Drug Revenue, Gross Margin and Market Share (2020-2025)
15.4 Octapharma
15.4.1 Company Profile
15.4.2 Main Business and Anticoagulant Reversal Drug Information
15.4.3 SWOT Analysis of Octapharma
15.4.4 Octapharma Anticoagulant Reversal Drug Revenue, Gross Margin and Market Share (2020-2025)
15.5 Pfizer
15.5.1 Company Profile
15.5.2 Main Business and Anticoagulant Reversal Drug Information
15.5.3 SWOT Analysis of Pfizer
15.5.4 Pfizer Anticoagulant Reversal Drug Revenue, Gross Margin and Market Share (2020-2025)
15.6 Dr. Reddy's Laboratories
15.6.1 Company Profile
15.6.2 Main Business and Anticoagulant Reversal Drug Information
15.6.3 SWOT Analysis of Dr. Reddy's Laboratories
15.6.4 Dr. Reddy's Laboratories Anticoagulant Reversal Drug Revenue, Gross Margin and Market Share (2020-2025)
15.7 Fresenius Kabi
15.7.1 Company Profile
15.7.2 Main Business and Anticoagulant Reversal Drug Information
15.7.3 SWOT Analysis of Fresenius Kabi
15.7.4 Fresenius Kabi Anticoagulant Reversal Drug Revenue, Gross Margin and Market Share (2020-2025)
15.8 Endo International
15.8.1 Company Profile
15.8.2 Main Business and Anticoagulant Reversal Drug Information
15.8.3 SWOT Analysis of Endo International
15.8.4 Endo International Anticoagulant Reversal Drug Revenue, Gross Margin and Market Share (2020-2025)
15.9 Teva Pharmaceutical
15.9.1 Company Profile
15.9.2 Main Business and Anticoagulant Reversal Drug Information
15.9.3 SWOT Analysis of Teva Pharmaceutical
15.9.4 Teva Pharmaceutical Anticoagulant Reversal Drug Revenue, Gross Margin and Market Share (2020-2025)
15.10 Viatris
15.10.1 Company Profile
15.10.2 Main Business and Anticoagulant Reversal Drug Information
15.10.3 SWOT Analysis of Viatris
15.10.4 Viatris Anticoagulant Reversal Drug Revenue, Gross Margin and Market Share (2020-2025)
15.11 Novartis
15.11.1 Company Profile
15.11.2 Main Business and Anticoagulant Reversal Drug Information
15.11.3 SWOT Analysis of Novartis
15.11.4 Novartis Anticoagulant Reversal Drug Revenue, Gross Margin and Market Share (2020-2025)
15.12 Lupin
15.12.1 Company Profile
15.12.2 Main Business and Anticoagulant Reversal Drug Information
15.12.3 SWOT Analysis of Lupin
15.12.4 Lupin Anticoagulant Reversal Drug Revenue, Gross Margin and Market Share (2020-2025)
15.13 Cipla
15.13.1 Company Profile
15.13.2 Main Business and Anticoagulant Reversal Drug Information
15.13.3 SWOT Analysis of Cipla
15.13.4 Cipla Anticoagulant Reversal Drug Revenue, Gross Margin and Market Share (2020-2025)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Anticoagulant Reversal Drug Report
Table Data Sources of Anticoagulant Reversal Drug Report
Table Major Assumptions of Anticoagulant Reversal Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Anticoagulant Reversal Drug Picture
Table Anticoagulant Reversal Drug Classification
Table Anticoagulant Reversal Drug Applications
Table Drivers of Anticoagulant Reversal Drug Market
Table Restraints of Anticoagulant Reversal Drug Market
Table Opportunities of Anticoagulant Reversal Drug Market
Table Threats of Anticoagulant Reversal Drug Market
Table COVID-19 Impact For Anticoagulant Reversal Drug Market
Table Raw Materials Suppliers
Table Different Production Methods of Anticoagulant Reversal Drug
Table Cost Structure Analysis of Anticoagulant Reversal Drug
Table Key End Users
Table Latest News of Anticoagulant Reversal Drug Market
Table Merger and Acquisition
Table Planned/Future Project of Anticoagulant Reversal Drug Market
Table Policy of Anticoagulant Reversal Drug Market
Table 2020-2030 North America Anticoagulant Reversal Drug Market Size
Figure 2020-2030 North America Anticoagulant Reversal Drug Market Size and CAGR
Table 2020-2030 North America Anticoagulant Reversal Drug Market Size by Application
Table 2020-2025 North America Anticoagulant Reversal Drug Key Players Revenue
Table 2020-2025 North America Anticoagulant Reversal Drug Key Players Market Share
Table 2020-2030 North America Anticoagulant Reversal Drug Market Size by Type
Table 2020-2030 United States Anticoagulant Reversal Drug Market Size
Table 2020-2030 Canada Anticoagulant Reversal Drug Market Size
Table 2020-2030 Mexico Anticoagulant Reversal Drug Market Size
Table 2020-2030 South America Anticoagulant Reversal Drug Market Size
Figure 2020-2030 South America Anticoagulant Reversal Drug Market Size and CAGR
Table 2020-2030 South America Anticoagulant Reversal Drug Market Size by Application
Table 2020-2025 South America Anticoagulant Reversal Drug Key Players Revenue
Table 2020-2025 South America Anticoagulant Reversal Drug Key Players Market Share
Table 2020-2030 South America Anticoagulant Reversal Drug Market Size by Type
Table 2020-2030 Brazil Anticoagulant Reversal Drug Market Size
Table 2020-2030 Argentina Anticoagulant Reversal Drug Market Size
Table 2020-2030 Chile Anticoagulant Reversal Drug Market Size
Table 2020-2030 Peru Anticoagulant Reversal Drug Market Size
Table 2020-2030 Asia & Pacific Anticoagulant Reversal Drug Market Size
Figure 2020-2030 Asia & Pacific Anticoagulant Reversal Drug Market Size and CAGR
Table 2020-2030 Asia & Pacific Anticoagulant Reversal Drug Market Size by Application
Table 2020-2025 Asia & Pacific Anticoagulant Reversal Drug Key Players Revenue
Table 2020-2025 Asia & Pacific Anticoagulant Reversal Drug Key Players Market Share
Table 2020-2030 Asia & Pacific Anticoagulant Reversal Drug Market Size by Type
Table 2020-2030 China Anticoagulant Reversal Drug Market Size
Table 2020-2030 India Anticoagulant Reversal Drug Market Size
Table 2020-2030 Japan Anticoagulant Reversal Drug Market Size
Table 2020-2030 South Korea Anticoagulant Reversal Drug Market Size
Table 2020-2030 Southeast Asia Anticoagulant Reversal Drug Market Size
Table 2020-2030 Australia Anticoagulant Reversal Drug Market Size
Table 2020-2030 Europe Anticoagulant Reversal Drug Market Size
Figure 2020-2030 Europe Anticoagulant Reversal Drug Market Size and CAGR
Table 2020-2030 Europe Anticoagulant Reversal Drug Market Size by Application
Table 2020-2025 Europe Anticoagulant Reversal Drug Key Players Revenue
Table 2020-2025 Europe Anticoagulant Reversal Drug Key Players Market Share
Table 2020-2030 Europe Anticoagulant Reversal Drug Market Size by Type
Table 2020-2030 Germany Anticoagulant Reversal Drug Market Size
Table 2020-2030 France Anticoagulant Reversal Drug Market Size
Table 2020-2030 United Kingdom Anticoagulant Reversal Drug Market Size
Table 2020-2030 Italy Anticoagulant Reversal Drug Market Size
Table 2020-2030 Spain Anticoagulant Reversal Drug Market Size
Table 2020-2030 Belgium Anticoagulant Reversal Drug Market Size
Table 2020-2030 Netherlands Anticoagulant Reversal Drug Market Size
Table 2020-2030 Austria Anticoagulant Reversal Drug Market Size
Table 2020-2030 Poland Anticoagulant Reversal Drug Market Size
Table 2020-2030 Russia Anticoagulant Reversal Drug Market Size
Table 2020-2030 MEA Anticoagulant Reversal Drug Market Size
Figure 2020-2030 MEA Anticoagulant Reversal Drug Market Size and CAGR
Table 2020-2030 MEA Anticoagulant Reversal Drug Market Size by Application
Table 2020-2025 MEA Anticoagulant Reversal Drug Key Players Revenue
Table 2020-2025 MEA Anticoagulant Reversal Drug Key Players Market Share
Table 2020-2030 MEA Anticoagulant Reversal Drug Market Size by Type
Table 2020-2030 Egypt Anticoagulant Reversal Drug Market Size
Table 2020-2030 Israel Anticoagulant Reversal Drug Market Size
Table 2020-2030 South Africa Anticoagulant Reversal Drug Market Size
Table 2020-2030 Gulf Cooperation Council Countries Anticoagulant Reversal Drug Market Size
Table 2020-2030 Turkey Anticoagulant Reversal Drug Market Size
Table 2020-2025 Global Anticoagulant Reversal Drug Market Size by Region
Table 2020-2025 Global Anticoagulant Reversal Drug Market Size Share by Region
Table 2020-2025 Global Anticoagulant Reversal Drug Market Size by Application
Table 2020-2025 Global Anticoagulant Reversal Drug Market Share by Application
Table 2020-2025 Global Anticoagulant Reversal Drug Key Vendors Revenue
Figure 2020-2025 Global Anticoagulant Reversal Drug Market Size and Growth Rate
Table 2020-2025 Global Anticoagulant Reversal Drug Key Vendors Market Share
Table 2020-2025 Global Anticoagulant Reversal Drug Market Size by Type
Table 2020-2025 Global Anticoagulant Reversal Drug Market Share by Type
Table 2025-2030 Global Anticoagulant Reversal Drug Market Size by Region
Table 2025-2030 Global Anticoagulant Reversal Drug Market Size Share by Region
Table 2025-2030 Global Anticoagulant Reversal Drug Market Size by Application
Table 2025-2030 Global Anticoagulant Reversal Drug Market Share by Application
Table 2025-2030 Global Anticoagulant Reversal Drug Key Vendors Revenue
Figure 2025-2030 Global Anticoagulant Reversal Drug Market Size and Growth Rate
Table 2025-2030 Global Anticoagulant Reversal Drug Key Vendors Market Share
Table 2025-2030 Global Anticoagulant Reversal Drug Market Size by Type
Table 2025-2030 Anticoagulant Reversal Drug Global Market Share by Type

Companies Mentioned

  • Boehringer Ingelheim
  • AstraZeneca
  • CSL Behring
  • Octapharma
  • Pfizer
  • Dr. Reddy's Laboratories
  • Fresenius Kabi
  • Endo International
  • Teva Pharmaceutical
  • Viatris
  • Novartis
  • Lupin
  • Cipla

Related Topics

Related Reports

Anticoagulant Reversal Drugs Market by Reversal Agent Type, Route of Administration, End User, Distribution Channel, Application, Dosage Form - Global Forecast to 2030 - Product Image

Anticoagulant Reversal Drugs Market by Reversal Agent Type, Route of Administration, End User, Distribution Channel, Application, Dosage Form - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From
Anticoagulant Reversal Drugs Market Size, Share & Trends Analysis Report By Product Type (Andexanet Alfa, Idarucizumab, Phytonadione (Vitamin K)), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Anticoagulant Reversal Drugs Market Size, Share & Trends Analysis Report By Product Type (Andexanet Alfa, Idarucizumab, Phytonadione (Vitamin K)), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Anticoagulant Reversal Drugs - Global Strategic Business Report - Product Image

Anticoagulant Reversal Drugs - Global Strategic Business Report

  • Report
  • 140 Pages
  • Global
From
Anticoagulant Reversal Drugs Market 2025-2029 - Product Image

Anticoagulant Reversal Drugs Market 2025-2029

  • Report
  • 157 Pages
  • Global
From
Direct Oral Anticoagulants (DOACs) Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Direct Oral Anticoagulants (DOACs) Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.